Ledger.Open graph →
SEC Form D · filed May 28, 2009

Elixir Pharmaceuticals, Inc

Offering
$25.0M
Sold
$12.0M
Exemption
—
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (12)

Steven M. Krausz · Menlo Park, CADirectorKenneth Greenberg · Boston, MADirectorDion Madsen · San Francisco, CADirectorRobert A. Van Doorn · Vancouver, British Columbia, CanadaDirectorPaul M. Martha · Cambridge, MAExec · DirectorKaren Roberts · Cambridge, MAExecPeter S. Distefano · Cambridge, MAExecVaughn M. Kailian · Boston, MADirectorKenneth Greenberg · South San Francisco, CADirectorRobert Kriebel · Cambridge, MAExecDion Madsen · VANCOUVER, British Columbia, CanadaDirectorVernon Cassin · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗